• Title/Summary/Keyword: Therapeutic rate

Search Result 1,104, Processing Time 0.025 seconds

Occurrence of Ovario-uterine Disease and Hormonal Therapeutic Effect in Dairy Cows (젖소에서 난소.자궁 질병 발생과 호르몬 치료 효과)

  • Ryu, Jae-Sun;Park, Chul-Ho;Kim, Sang-Il;Bae, Jae-Han;Suh, Guk-Hyun;Kim, Jae-Pung;Park, Sang-Guk;Lee, Suk-Kyung;Son, Chang-Ho;Oh, Ki-Seok
    • Journal of Embryo Transfer
    • /
    • v.26 no.1
    • /
    • pp.37-43
    • /
    • 2011
  • A total 5,946 cows from 24 dairy farms were carried out for the improvement of reproductive performance. Dairy cows in post-parturition 30 day were performed periodic reproductive examination to check for recovery of post-parturition ovary and uterus and for the early diagnosis of reproductive disease. The results obtained from this studies were as follow. The result of 1,126 cows with ovario-uterine disease were 579 slient heat and error of estrus detection (51.4%), 296 ovarian disease (26.3%), 248 uterine disease (22%), mummification and freematin were each 1 head (0.1%), respectively. Hormonal therapeutic effects were follicular cyst 81.5%, luteal cyst 90.7%, endometritis 86.9%, mucometra 90.1%, pyometra 60.9%, respectively. In cows, even if the 1st treatment fails, 2nd, 3rd treatment were performed. Therapeutic effect of 2nd, 3rd were reduced, but the number of cured cows were gradually increased. The cured cows after hormonal treatment were performed service repeatedly and the cumulative conception rate were increased. The cows treated with hormones at first service, the conception rate were follicular cyst 26%, luteal cyst 64.1%, endometritis 38.7%, mucometra 40%, pyometra 20.5%, respectively. The cumulative conception rates were increased by repeated service follicular cyst 57.3%, luteal cyst 84.6%, endometritis 67%, mucometra 75%, pyometra 64.1%, respectively.

Acute Response to Co-60 Total Body Irradiation (TBI) With 600 cGy at 3 Different Does Rates in the Mice (코발트-60 원격치료기를 이용한 전신 방사선 조사에서 선량율의 차이에 따른 급성효과)

  • Kang Cheol Hoon;Kum Sung Kyu;Shin Sei One;Kim Myung Se
    • Radiation Oncology Journal
    • /
    • v.8 no.2
    • /
    • pp.151-154
    • /
    • 1990
  • The acute effects of variable dos rates to total body irradiation (TBI) were investigaed with 600 cGy of single exposure in the mice as a preclinical model. Total 80 mice (ICR) were used. Twenty of which sewed as controls, receiving no irradiation. All irradiated mice showed a universal decline in their weight and white blood cell count. The degree of weight loss and leukopenia were similar at 3 different dos rate but slightly prominent with 15 cGy/minute group. The degree of recovery among the groups showed no dose rate dependence. Our results suggest that TBI with 15 cGy/mimute may be applicable for clinical therapy with careful evaluation of patient's condition.

  • PDF

Transdermal Permeation Characteristics of Anti Cholesterol Ointment using Nicotinic acid N-oxide (Nicotinic acid N-oxide를 이용한 항콜레스테롤 연고의 경피 투과 특성)

  • Jung, Duck-Chae;Kim, Kyu-Won
    • Journal of the Korean Applied Science and Technology
    • /
    • v.25 no.2
    • /
    • pp.123-129
    • /
    • 2008
  • Transdermal therapeutic system(TTS) is often used as the method of drug dosage into the epidermic skin. Natural polymer were selected as ointment material of TTS. We investigated the permeation of natural polymer ointment containing drug in rat skin using horizontal membrane cell model. Permeation properties of materials were investigated for water-soluble drug such as Nicotinic acid N-oxide in vitro. These results showed that skin permeation rate of drug across the composite was mainly dependent on the property of ointment base and drug. Proper selection of the polymeric materials which resemble and enhance properties of the delivering drug was found to be important in controlling the skin permeation rate. This result suggests a possible use of natural polymer ointment base as TTS of antihyperlipoproteinemic agent.

Property of Dose Distribution in Accordance with Dose Rate Variation in Intensity Modulated Radiation Therapy (세기조절방사선치료에서 선량율 변화에 따른 선량분포 특성)

  • Kang, Min-Kyu;Kim, Sung-Joon;Shin, Hyun-Soo;Kim, Sung-Kyu
    • Progress in Medical Physics
    • /
    • v.21 no.2
    • /
    • pp.218-222
    • /
    • 2010
  • As radiation is irradiated from various directions in intensity modulated radiation therapy (IMRT), longer treatment time than conventional treatment method is taken. In case of the patients who have problem to keep same posture for long time because of pain and injury, reducing treatment time through increased dose rate is a way for effective treatment. This study measured and found out the variation of dose and dose distribution in accordance with dose rate variation. IMRT treatment plan was set up to investigate from 5 directions - $0^{\circ}$, $72^{\circ}$, $144^{\circ}$, $216^{\circ}$, $288^{\circ}$ - using ECLIPSE system (Varian, SomaVision 6.5, USA). To confirm dose and dose rate in accordance with dose rate variation, dose rate was set up as 100, 300, 500 MU/min, and dose and dose distribution were measured using ionization chamber (PTW, TN31014) and film dosimeter (EDR2, Kodak). At this time, film dosimeter was inserted into acrylic phantom, then installed to run parallel with beam's irradiating direction, 21EX-S (Varian, USA) was utilized as linear accelerator for irradiation. The measured film dosimeter was analyzed using VXR-16 (Vidar System Corporation) to confirm dose distribution.

The Result of Combined Modality Treatment for Non-Hodgkin's Lymphoma of Head and Neck (두경부 악성 임파종에 대한 병용치료의 결과)

  • Kim Jae Cheol;Kim Sang Bo;Ryu Samuel;Park In Kyu
    • Radiation Oncology Journal
    • /
    • v.8 no.2
    • /
    • pp.255-260
    • /
    • 1990
  • From April 1985 to September 1989, 26 patients with stage I and II non-Hodgkin's lymphoma of unfavorable histology localized in head and neck region were treated with combined modality (combination chemotherapy plus radiotherapy) at the Department of Therapeutic Radiology in Kyungpook National University Hospital. Of the 26 patients, 23 showed complete response and 3 partial response. Between these two groups there were no statistical differences according to the variables. Three-year survival and disease-free survival rate were $62.4{\%}$ and $65.2{\%}$, respectively. Unilateral involvement of neck node (p<0.05), radiation dose over 5000 cGy (p<0.01), and 6 or more cycles chemotherapy (p=0.06) had a favorable effect on 3-year survival rate. There were 8 recurrences including 3 partial responders, 1 local failure, 1 distant failure, 1 contiguous failure, and 2 simultaneous local and distant failure. It could be suggested that combined modality treatment might be necessary for the treatment of stage I and II Non-Hodgkin's lymphoma of unfavorable histology.

  • PDF

Analytical comparison of structural changes of plastic cell-based therapeutic drug storage containers when exposed to cryogenic environments (플라스틱 세포치료제 보관용기의 극저온 환경 노출 시 구조적 변화에 대한 해석적 비교)

  • Park, Jeong-Yeon;Lee, Dong-Mok;Lee, Jienny;Lee, Sun-ray;Yoon, Gil-Sang
    • Design & Manufacturing
    • /
    • v.14 no.2
    • /
    • pp.1-6
    • /
    • 2020
  • Recently, research and commercialization related to the field of cell-based therapeutic drug development has been actively conducted. In order to maintain cell viability and prevent contamination, refrigeration preservation devices, such as CRF (controlled rate freezer) or vapor type LN2 tanks have been developed. On the other hand, the storage container for liquid nitrogen tanks currently on sale minimizes the flow structure to prevent structural defects when stored in a liquid nitrogen tank having a high thermal conductivity than vapor nitrogen. If the cell-based treatment drug is stored in the gaseous LN2 tank as it is, the cell survival after thawing is greatly reduced. It was estimated that the existing storage container structure was a factor that prevented the rapid entry and circulation of gaseous nitrogen into the container. Therefore, this study intends to propose a new supercellular storage container model that can maintain the mechanical strength while maximizing the fluid flow structure. To this end, we estimated that the structural change of the storage container effects on the equivalent stress formed around the through-holes of them when exposed to a cryogenic environment using thermal-structural coupled field analysis. As a result of storage experiments in the gas phase tank of the cell-based therapeutic agent using the developed storage container, it was confirmed that the cell growth rate was improved from 66% to 77%, which satisfied the transportation standards of the FDA(Food and Drug Administration) cell-based therapeutic agent.

Medical Therapeutic Effect of Hyperthyroidism - Comparison of antithyroid therapy and $^{131}I$ Therapy - (갑상선기능항진증(甲狀腺機能亢進症)의 내과적(內科的) 치료효과(治療效果) - 방사성동위원소(放射性同位元素) ($^{131}I$)치료(治療)와 항갑상선제(抗甲狀腺劑) 치료(治療)의 비교검토(比較檢討) -)

  • Lee, Kyu-Bo
    • The Korean Journal of Nuclear Medicine
    • /
    • v.14 no.2
    • /
    • pp.35-40
    • /
    • 1980
  • In order to compare the therapeutic effect as well as side effects between antithyroid therapy and radioiodine therapy in hyperthyroidism, the author evaluated 111 cases of hyperthyroidism which were composed of 57 patients with antithyroid treatment, 23 patients with combined treatment comprising of antithyroid and radioactive iodine ($^{131}I$) and 31 patients with treatment of $^{131}I$ alone. The $^{131}I$ treatment was limited to older age, above 20 years of age, and not employed in patients with pregnancy and lactation. The patients treated with antithyroid belonged to relatively younger age, and also milder in symptoms and thyroid function tests. The remission rate of antithyroid therapy group was 97.8% within 16 months. Among them the early remission rate occured within 4 months was found to be 21.7%. The combined therapy group, having prescribed more severe cases, showed the remission rate to be 75% within 16 months. The remission rate of $^{131}I$ therapy group revealed 90.9% within 16 months. Among them the early remission rate taking place within 4 months disclosed 16.7%. The side effects of antithyroid drug, propylthiouracil, were noted as follows: itching (2.7%) skin rashes (1.3%), and adverse enlargement of goiter (10.7%). The side effects $^{131}I$ therapy were transient hypothyroidism(3.9%) permanent hypothyroidism (7.8%) and itching (2.0%).

  • PDF

Clinical Result of Combined Radiotherapy and Hyperthermia Induced by 915 MHz Microwave and Ultrasound in Locally Advanced Malignant Tumors of Head and Neck (915 MHz 극초단파 및 초음파를 이용한 온열치료와 방사선치료 병합치료에 의한 두경부암의 치료성적)

  • Koh Kyoung-Hwan;Park Young-Hwan;Cho Chul-Koo;Yoo Seong-Yul
    • Korean Journal of Head & Neck Oncology
    • /
    • v.6 no.1
    • /
    • pp.40-45
    • /
    • 1990
  • Thirty five lesions of 35 patients with locally advanced malignant tumors of head and neck were received thermoradiotherapy with ultrasound and/or 915 MHz microwave. Most of all patients were failed with previous conventional therapeutic trial. Hyperthermia had been done immediately after radiotherapy, twice a week, $43^{\circ}C$ for one hour and radiotherapy had been done 5 fractions per week with a fraction size of 2 Gy up to total 30 to 60 Gy. Conclusions are as follows; 1) Total response rate (CR+PR) of thermoradiotherapy with microwave and ultrasound was 80%. 2) Tumor depth, minimum temperature of tumor center, number of heat fraction and irradiation dose were statistically significant factors affecting response. 3) Hyperthermia with microwave and ultrasound can be used efficiently to control locally advanced malignant tumors in head and neck whether previously received near tolerance dose of radiotherapy or not.

  • PDF

Clinical Applications of Microwave and Ultrasound in Hyperthermia: Preliminary Results (극초단파와 초음파온열치료에 의한 각종암의 임상치료)

  • Koh Kyoung Hwan;Park Young Hwan;Cho Chul Koo;Yoo Seong Yul
    • Radiation Oncology Journal
    • /
    • v.6 no.1
    • /
    • pp.75-80
    • /
    • 1988
  • Twenty seven lesions of 25 patients with locally advanced malignant tumors were treated with combined hyperthermia introduced by microwave and ultrasound and radiotherapy. Most of all patients were failed with previous conventional therapeutic trial. Hyperthermia had been done immediately after radiotherapy, twice a week, $43^{\circ}C$ for one hour and radiotherapy had been done 5 fractions per week with fraction size of 2Gy upto 30 to 60Gy. Conclusions are as follows. 1. Total response rate (PR+PR) to thermoradiotherapy with microwave and ultrasound was $81\%$. 2. Tumor depth, minimum temperature of tumor center, number of heat fraction and radiation dose were statistically significant factors affecting response. 3. Hyperthermia with microwave and ultrasound can be used efficiently to control locally advanced malignant disease whether previously received near tolerance dose of radiotherapy or not.

  • PDF

The Effect of Neutron Therapy on Head and Neck Cancer (두경부암(頭頸部癌)에서 중성자선(中性子線) 치료(治療)의 효과(?果))

  • Yoo Seong-Yul;Koh Kyoung-Hwan;Cho Chul-Ku
    • Korean Journal of Head & Neck Oncology
    • /
    • v.5 no.1
    • /
    • pp.31-38
    • /
    • 1989
  • The result of neutron therapy on head and neck cancer using KCCH -Cyclotron neutron which had been using from October 1986 to September 1989 in the Korea Cancer Center Hospital. Among the total of 27 patients the cases of malignant salivary gland tumor were 14 and the cases of advanced head and neck cancer of AJCC stage IV were 13. The local control rate was 80% in malignant salivary gland tumor and 46.2% in advanced head and neck cancer. The 2 year survival rate was 60% in malignant salivary gland tumor and 38.5% in advanced head and neck cancer. Although there was no significant difference in prognosis according to the pathologic types, squamous cell carcinoma revealed a pattern of poor prognosis. The major complication from the neutron therapy had developed 7.1% in malignant salivary gland tumor and 23.1% in advanced head and neck cancer. In conclusion, neutron therapy is superior in the treatment of malignant salivary gland tumor and also effective in the treatment of advanced head and neck cancer when it can avoid to treat some site of low tolerance.

  • PDF